Blogs

Germany has become one of Europe’s leading destinations for advanced cancer care, particularly in the field of immunotherapy. In 2022, an estimated 530,000 new cancer cases were expected in Germany, underscoring the potential benefits for many pati

Germany operates one of the world’s largest hospital networks, and selecting the right one is crucial. As of 2024, the country counted 1,874 hospitals offering 476,924 beds.<ref>1</ref> That access is reflected in international comparis

Thanks to advancements in science and medicine, prostate cancer can now be defeated even in its late stages, even when metastases have spread. At AiroMedical, we have gathered real stories from cancer patients and insights from doctors on how to combat the disease effectively. We want to share one prostate cancer story from one of our patients from the USA.

About 80% of all salivary gland tumors are in the parotid gland. 12% of all cases of oral and pharyngeal cancer are related to the parotid gland. Parotid gland cancer develops simultaneously from both sides of the face in 10-15% of cases. About 80% of all parotid tumors are benign.

About 96% of all confirmed neurofibromatosis cases worldwide are represented by neurofibromatosis type 1. On average, only one human out of 25,000 got a neurofibromatosis type 2. About 0,3% of affected patients are not developing a single symptom but still can pass this condition to their offspring.

In the USA, only about 390 new cases of thymus cancer are discovered yearly. Every two in three patients with thymus cancer are asymptomatic when diagnosed. Patients with thymus cancer have 28% more chances of developing other types of cancer. Thymus cancer represents 20% of all tumors in the mediastinum.